Coordination of world-class research facilities

Four unique world-class research facilities are located just a few hours apart. Properly utilised, a Nordic centre for world-leading life science innovation and...

Anna Törner: Kalashnikovs in a new guise

Thanks to resisting European regulatory authorities, Europe has been spared the opioid epidemic. In the 1960s, the situation was the opposite as the American ph...

Björn Arvidsson: ”We need to change perspective”

If you say “life science” to a person on the street and ask them to explain what it is, you will probably get no good answer. The same question to your network ...

Krönika: Collaboration across borders

Delivering drugs with small devices

There are many challenges to overcome when delivering a drug orally. Getting the drug to survive the low pH of the ventricle and being released at the correct s...

Oasmias villkor klara

Två kronor per aktier – så ser villkoren ut för den tidigare aviserade emission på cirka 400 miljoner som läkemedelsutvecklaren Oasmia förbereder. Börskursen fa...

A growing industry in Denmark: “One new life science company a week”

The life science sector in eastern Denmark continues to grow in the number of employees, as well as the number of companies. An emerging problem is the shortage...

Elicera develops CAR-T against solid tumours – may become the first in the world

Today, there are five EU-approved CAR-T therapies, all focused on different types of blood cancer, but no one has yet succeeded in making the method work agains...

Brexit creeping closer – or?

In this column, lawyer Pernilla Norman, tries to sort out the different Brexit options.

Marie Gårdmark: New incentives for orphan products on its way

"Let’s hope that the learnings from development of new therapies for rare diseases will spill over to more common conditions, orphan products paving the wave fo...

Anna Törner: To kill your darlings

Hopes were high when Anna Törner and her colleague started a study on a dietary supplement that seemed unbelievably good. “Enthusiastically, we dreamed of excit...

Ny kunskap om sällsynt grundämne

Forskare från Göteborgs universitet har lyckats skapa små mängder av världens mest sällsynta grundämne.

Atheras studie av hjärtsvikt igång

Den första patienten har behandlats i studien med en ny terapeutisk antikropp från Athera. Studien genomförs på 11 sjukhus och inkluderar patienter med akut hjä...

Medicpen förlorar upphandling

”Vi kämpar på med målet att leda förändringen av medicinhanteringssystemen”

Brexit looking back and looking forward

More than 3 years have passed after the vote and there is still uncertainty around the outcome although the UK December 12 election set a clearer course towards...

Hello Angelica Loskog!

Life Science Sweden would like to know more about Angelica Loskog and interviews her about her life as a researcher.

Landets life science-strategi – var med och påverka den!

Det statliga life science-kontorets chef Jennie Nordborg vill veta vad de ska ha med i den nationella life science-strategin. Nu vill hon ha din åsikt!

TV: Spelifieringen ändrar beteenden

Beteenden och livsstil kan påverkas med mer lekfullhet. Life science-branschen fick lära sig mer om ämnet vid möte i Göteborg.

A world-class research village

Eight years ago, Medicon Village was set up in Lund. Since then, this hub for research, innovation and business has developed enormously, and today the life sci...

TV: Vårdutbildningar ska bli mer tekniska

Agneta Holmäng, professor och dekan vid Sahlgrenska Akademin, tänker föra in mer teknik i utbildningen av vårdpersonal.

TV: Mjukvaruföretag går in i USA

Svenskt företag med stödsytem för läkemedelsutveckling år in i USA. Detta är framgångsfaktorerna.

Pilots want to live too

New rules for diagnostic products, but who will certify them? “An extreme shortage area”

In less than two weeks, new and stricter EU rules will enter into force for thousands of products used in important diagnoses of, among other things, cancer and...

Pharma-on-Demand

Make or buy? That is the question that the pharma world has been asking more and more in the last couple of decades. Pernille Hemmingsen is moderator at Pharma ...